Highlights and Quick Summary
- R&D Expenses for the quarter ending December 31, 2022 was $3.76 Million (a 41.39% increase compared to previous quarter)
- Year-over-year quarterly R&D Expenses increased by 73.24%
- Annual R&D Expenses for 2022 was $11.3 Million (a 60.57% increase from previous year)
- Annual R&D Expenses for 2021 was $7.02 Million (a 0.0% decrease from previous year)
- Annual R&D Expenses for 2021 was $7.02 Million (a 133.92% increase from previous year)
- Twelve month R&D Expenses ending December 31, 2022 was $11.8 Million (a 5.51% increase compared to previous quarter)
- Twelve month trailing R&D Expenses increased by 12.96% year-over-year
Trailing R&D Expenses for the last four month:
31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
---|---|---|---|
$11.8 Million | $11.2 Million | $11.3 Million | $10.4 Million |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical R&D Expenses of Benitec Biopharma Limited
Most recent R&D Expensesof BNTC including historical data for past 10 years.Interactive Chart of R&D Expenses of Benitec Biopharma Limited
Benitec Biopharma Limited R&D Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $3.76 | $2.66 | $3.18 | $2.17 | $11.27 |
2021 | $3.15 | $2.78 | $2.32 | $2.76 | $7.02 |
2020 | $1.17 | $0.77 | $1.17 | $0.81 | $3.0 |
2019 | – | – | $0.6 | $0.42 | $4.57 |
2018 | – | – | – | – | $5.34 |
2017 | – | – | – | $1.11 | $5.22 |
2016 | – | – | – | $1.91 | $9.68 |
2015 | – | – | – | – | $5.21 |
2014 | – | – | – | – | $3.45 |
2013 | – | – | – | – | $1.32 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology